Skip to main content

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Introduction

A South Carolina jury failed to arrive at a unanimous decision whether Johnson & Johnson was responsible for the death of the 30-year old attorney, whose family claimed she suffered from mesothelioma due to the exposure to J&J's talcum powder containing asbestos traces.

A lawyer for the family insists that the daily use of baby powder led to the death and stated they will retry the case soon. The other defendants, in this case, were the U.S. unit of talc supplier Imerys SA, and a local unit of drugstore chain Rite Aid.

J&J is facing around 9,000 cases over claims that its talcum use led to the diagnosis of ovarian cancer in women due to traces of asbestos present as an ingredient in the baby powder when used for feminine hygiene purposes.

Similar allegations are filed against J&J in state courts in California, New Jersey, and Delaware and consolidated for pre-trial proceedings in the U.S. District Court for the District of New Jersey MDL No. 2738 (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ 100% FREE — 60 mins Legal Transcription and 2 Demand Letters!                 
🔒 No AI. No Risk. No Contract. 100% HIPAA-Compliant, Done by Attorneys & Doctors.

Only 06 Slots left for Law Firms—Offer Ends Sep 30!